Chunmei Zhang & Wancheng Zhao. (2022). The efficacy and safety of angiogenesis inhibitors for recurrent ovarian cancer: A meta‑analysis. BMC.
Chicago Style (17th ed.) CitationChunmei Zhang and Wancheng Zhao. The Efficacy and Safety of Angiogenesis Inhibitors for Recurrent Ovarian Cancer: A Meta‑analysis. BMC, 2022.
MLA (9th ed.) CitationChunmei Zhang and Wancheng Zhao. The Efficacy and Safety of Angiogenesis Inhibitors for Recurrent Ovarian Cancer: A Meta‑analysis. BMC, 2022.
Warning: These citations may not always be 100% accurate.